Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-08

Clinical Trial Update: Quadrant Versus Superficial Parotidectomy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing quadrant versus superficial parotidectomy for pleomorphic adenoma of the parotid gland has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mansoura University | Conditions: Pleomorphic Adenoma of the Parotid Gland | Phase 2, Phase 3 | Status: WITHDRAWN